The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes
Background: Since its discovery 100 years ago, insulin, as the ‘cure’ for type 1 diabetes, has rescued the lives of countless individuals. As the century unfolded and the autoimmune nature of type 1 diabetes was recognised, a darker side of insulin emerged. Autoimmunity to insulin was found to be an...
Main Author: | Leonard C. Harrison |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Molecular Metabolism |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212877821001332 |
Similar Items
-
Interferon and autoantigens: intersection in autoimmunity
by: Brendan Antiochos, et al.
Published: (2023-05-01) -
Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases
by: Ganesan Vinitha, et al.
Published: (2016-05-01) -
A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins
by: Wei Zhang, et al.
Published: (2019-06-01) -
DFS70/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS, and cancer
by: Anamika eBasu, et al.
Published: (2015-03-01) -
Identification of Novel Native Autoantigens in Rheumatoid Arthritis
by: Thomas B. G. Poulsen, et al.
Published: (2020-05-01)